Additionally, we have reported in lung cancer that 2HF directly binds to Rlip, inhibiting its transport functions and potentiating the anticancer effects of anti-Rlip antibodies, indicating that Rlip inhibition is a mechanism of 2HF activity [14]. Here, RALBP1 is linked to lung carcinoma.